|
|
Volumn 42, Issue 9, 2002, Pages 1230-1237
|
|
NAT screening of blood and plasma donations: evolution of technology and regulatory policy.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEPATITIS B SURFACE ANTIGEN;
VIRUS DNA;
VIRUS RNA;
BLOOD;
BLOOD DONOR;
BLOOD TRANSFUSION;
DISEASE TRANSMISSION;
DNA MICROARRAY;
GENETICS;
HEPATITIS VIRUS;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION CONTROL;
ISOLATION AND PURIFICATION;
LEGAL ASPECT;
LICENSING;
MASS SCREENING;
METHODOLOGY;
PARVOVIRUS;
PLASMA;
POLICY;
PRACTICE GUIDELINE;
REVIEW;
SENSITIVITY AND SPECIFICITY;
STANDARD;
VIROLOGY;
VIRUS HEPATITIS;
VIRUS INACTIVATION;
VIRUS INFECTION;
BLOOD;
BLOOD DONORS;
BLOOD TRANSFUSION;
DISEASE TRANSMISSION, HORIZONTAL;
DNA, VIRAL;
HEPATITIS B SURFACE ANTIGENS;
HEPATITIS VIRUSES;
HEPATITIS, VIRAL, HUMAN;
HIV INFECTIONS;
HIV-1;
HUMANS;
INFECTION CONTROL;
LICENSURE;
MASS SCREENING;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PARVOVIRIDAE INFECTIONS;
PARVOVIRUS B19, HUMAN;
PLASMA;
PRACTICE GUIDELINES;
PUBLIC POLICY;
RNA, VIRAL;
SENSITIVITY AND SPECIFICITY;
VIRUS INACTIVATION;
|
|
EID: 0036730114
PISSN: 00411132
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1537-2995.2002.00183.x Document Type: Review |
|
Times cited : (52)
|
|
References (16)
|
